septopal 4.5 mg/ kule
zimmer biomet norway as - gentamicinsulfat - kjede til implantasjon - 4.5 mg/ kule
septopal mini 1.7 mg/ kule
zimmer biomet norway as - gentamicinsulfat - kjede til implantasjon - 1.7 mg/ kule
incivo
janssen-cilag international n.v. - telaprevir - hepatitt c, kronisk - antivirale midler til systemisk bruk - incivo, i kombinasjon med peginterferon alfa og ribavirin, er indisert for behandling av genotype-1, kronisk hepatitt c hos voksne pasienter med kompensert leversykdom (inkludert skrumplever):hvem er behandling naiv, som tidligere har vært behandlet med interferon alfa (pegylated eller ikke-pegylated) alene eller i kombinasjon med ribavirin, inkludert relapsers, delvise besvarelser og null-respondere.
blincyto
amgen europe b.v. - blinatumomab - forløpercellelymfoblastisk leukemi-lymfom - antineoplastiske midler - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.
estalis 50 mikrog/24 timer / 250 mikrog/24 timer
sandoz a/s - Østradiolhemihydrat / noretisteronacetat - depotplaster - 50 mikrog/24 timer / 250 mikrog/24 timer
estradot 25 mikrog/24 timer
sandoz a/s - Østradiolhemihydrat - depotplaster - 25 mikrog/24 timer
estradot 37.5 mikrog/24 timer
sandoz a/s - Østradiolhemihydrat - depotplaster - 37.5 mikrog/24 timer
estradot 50 mikrog/24 timer
sandoz a/s - Østradiolhemihydrat - depotplaster - 50 mikrog/24 timer
estradot 75 mikrog/24 timer
sandoz a/s - Østradiolhemihydrat - depotplaster - 75 mikrog/24 timer